參考文獻(xiàn)/References:
[1] BUBOVÁ K,FOREJTOVÁ S,ZEGZULKOVÁ K,et al.Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria:baseline clinical characteristics and subset differences in a single centre cohort[J].BMJ Open,2019,9(4):e024713.
[2] DUBREUIL M,DEODHAR A A.Axial spondyloarthritis classification criteria:the debate continues[J].Curr Opin Rheumatol,2017,29(4):317-322.
[3] 任偉凡,胡勁濤,全仁夫,等.強(qiáng)直性脊柱炎易感基因的相關(guān)研究進(jìn)展[J].中醫(yī)正骨,2019,31(4):48-51.
[4] 劉越,趙艷梅,夏群.強(qiáng)直性脊柱炎的診斷與治療進(jìn)展[J].中國(guó)矯形外科雜志,2015,23(3):235-238.
[5] BARALIAKOS X,BRAUN J.Hip involvement in ankylosing spondylitis:what is the verdict?[J].Rheumatology(Oxford),2010,49(1):3-4.
[6] AKKOÇ N,YARKAN H,KENAR G,et al.Ankylosing spondylitis:HLA-B*27-positive versus HLA-B*27-negative disease[J].Curr Rheumatol Rep,2017,19(5):26.
[7] 張亮,滿斯亮,李宏超,等.強(qiáng)直性脊柱炎患者髖關(guān)節(jié)受累不同階段股骨近端形態(tài)學(xué)參數(shù)與骨密度變化的相關(guān)性分析[J].中華骨與關(guān)節(jié)外科雜志,2019,12(10):765-770.
[8] 謝海琴,張威威,陳香梅,等.超聲評(píng)估強(qiáng)直性脊柱炎胸鎖關(guān)節(jié)受累情況[J].中國(guó)超聲醫(yī)學(xué)雜志,2018,34(3):214-216.
[9] 呂智楨,孔令軍,房敏.觸診在脊柱病“筋骨評(píng)估”中的重要性[J].中醫(yī)正骨,2019,31(5):18-19.
[10] 張寶方,葉瓊玉,林小影.高頻超聲在評(píng)價(jià)小兒?jiǎn)蝹?cè)髖關(guān)節(jié)滑膜炎治療效果中的應(yīng)用[J].中國(guó)醫(yī)藥科學(xué),2019,9(21):190-193.
[11] 中華醫(yī)學(xué)會(huì)風(fēng)濕病學(xué)分會(huì).強(qiáng)直性脊柱炎診斷及治療指南[J].中華風(fēng)濕病學(xué)雜志,2010,14(8):557-559.
[12] 朱家安,邱邐.肌骨超聲診斷學(xué)[M].北京:人民衛(wèi)生出版社,2019:121-122.
[13] 王月香,曲文春.肌骨超聲診斷[M].北京:人民軍醫(yī)出版社,2013:245-251.
[14] 劉曉敏,陳銀河.強(qiáng)直性脊柱炎與細(xì)胞毒性T細(xì)胞相關(guān)抗原-4基因多態(tài)性的Meta分析[J].中華風(fēng)濕病學(xué)雜志,2017,21(8):547-552.
[15] LIN H,GONG Y Z.Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27 associated ankylosing spondylitis:a meta-analysis[J].Rheumatol Int,2017,37(8):1267-1280.
[16] CRUYSSEN B V,MUÑOZ-GOMARIZ E,FONT P,et al.Hip involvement in ankylosing spondylitis:epidemiology and risk factors associated with hip replacement surgery[J].Rheumatology(Oxford),2010,49(1):73-81.
[17] 李虎,李儒軍,曹宸喜,等.趨化素樣因子1過(guò)表達(dá)促進(jìn)強(qiáng)直性脊柱炎髖關(guān)節(jié)韌帶成纖維細(xì)胞增殖和向成骨細(xì)胞轉(zhuǎn)化的實(shí)驗(yàn)研究[J].中華風(fēng)濕病學(xué)雜志,2017,21(9):614-621.
[18] 龔家川.影響強(qiáng)直性脊柱炎患者髖關(guān)節(jié)受累的危險(xiǎn)因素分析[J].中醫(yī)正骨,2017,29(6):25-27.
[19] 楊秀文,周作斌,李文星.強(qiáng)直性脊柱炎髖關(guān)節(jié)病變的MR與CT影像學(xué)表現(xiàn)研究[J].中國(guó)CT和MRI雜志,2017,15(1):121-124.
[20] 王家富,林耀云,林琳,等.強(qiáng)直性脊柱炎髖關(guān)節(jié)病變患者HLA-B27與CT、MRI聯(lián)合診斷價(jià)值分析[J].中國(guó)CT和MRI雜志,2017,15(10):128-131.
[21] 陳超,徐凱.強(qiáng)直性脊柱炎的影像診斷[J].湖南中醫(yī)藥大學(xué)學(xué)報(bào),2013,33(2):84-85.
[22] 冷曉明,姜?jiǎng)倥?黃勇,等.MRI測(cè)量股骨頭壞死塌陷前期髖關(guān)節(jié)軟骨的厚度及表觀彌散系數(shù)分析[J].中國(guó)CT和MRI雜志,2015,13(7):101-103.
[23] 李艷捧,杜曉猛,李興華,等.正常成人髖關(guān)節(jié)軟骨厚度的MRI測(cè)量研究[J].中國(guó)CT和MRI雜志,2016,14(3):111-112.
[24] 韓曉鳳.雙能量CT與高頻超聲診斷痛風(fēng)性關(guān)節(jié)炎63例的臨床分析[J].中國(guó)CT和MRI雜志,2018,16(5):134-136.
[25] 周勝虎,甄平,高明暄,等.髖關(guān)節(jié)置換術(shù)治療強(qiáng)直性脊柱炎髖關(guān)節(jié)骨性強(qiáng)直[J].中華創(chuàng)傷雜志,2013,29(12):1159-1162.
相似文獻(xiàn)/References:
[1]閻曉霞,任之強(qiáng),仝允輝,等.布魯氏菌性脊柱炎3例[J].中醫(yī)正骨,2015,27(06):64.
[2]趙偉光,劉振武,劉利,等.強(qiáng)直性脊柱炎合并右側(cè)股骨頭和股骨頸骨溶解癥1例[J].中醫(yī)正骨,2015,27(01):75.
[3]黃建武,黃建華,黃影.腫瘤壞死因子-α在強(qiáng)直性脊柱炎活動(dòng)期患者中的表達(dá)[J].中醫(yī)正骨,2013,25(11):22.
[4]張董喆,孔超,張建福.針刺夾脊穴結(jié)合督灸治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2014,26(07):58.
[5]吳建國(guó).強(qiáng)直性脊柱炎并發(fā)脊柱骨折的影像學(xué)表現(xiàn)[J].中醫(yī)正骨,2013,25(06):31.
[6]謝國(guó)華,薛峰,楊建平,等.強(qiáng)直性脊柱炎脊柱應(yīng)力性骨折的診斷[J].中醫(yī)正骨,2012,24(12):72.
[7]張萬(wàn)義,張永紅,王笑青.雙醋瑞因膠囊聯(lián)合柳氮磺胺吡啶腸溶片與右旋布洛芬膠囊治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2012,24(06):26.
ZHANG Wan-yi*,ZHANG Yong-hong,WANG Xiao-qing.*.Study on the curative effects of diacerein capsules combined with sulfasalazine enteric-coated tablets and dextral ibuprofen capsules in the treatment of ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(08):26.
[8]黃建華,黃建武,陳金春,等.早期強(qiáng)直性脊柱炎血管內(nèi)皮生長(zhǎng)因子、C反應(yīng)蛋白
表達(dá)水平的臨床研究[J].中醫(yī)正骨,2012,24(02):9.
HUANG Jian-hua*,HUANG Jian-wu,CHEN Jin-chun,et al.Clinical research on the expression of VEGF、CRP in early ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(08):9.
[9]王笑青,張永紅,王玉麗,等.常規(guī)藥物口服配合中藥離子導(dǎo)入治療強(qiáng)直性脊柱炎肌腱附著點(diǎn)炎[J].中醫(yī)正骨,2011,23(10):18.
WANG Xiao-qing*,ZHANG Yong-hong,WANG Yu-li,et al.A study on the curative effects of oral conventional drugs combined with traditional Chinese medicine iontophoresis on ankylosing spondylitis tendon enthesitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(08):18.
[10]劉紅軍.單節(jié)段楔形截骨結(jié)合椎弓根A-F系統(tǒng)內(nèi)固定
治療強(qiáng)直性脊柱炎脊柱后凸畸形[J].中醫(yī)正骨,2011,23(09):65.
[11]戴霞華,李寅潔.指導(dǎo)性功能鍛煉在兒童強(qiáng)直性脊柱炎護(hù)理中的應(yīng)用[J].中醫(yī)正骨,2015,27(10):78.
[12]張夢(mèng)雨,鮑鐵周,田江波.督脈隔姜灸聯(lián)合柳氮磺吡啶腸溶片口服及
功能鍛煉治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2015,27(09):44.
[13]赫軍,諸葛天諭,李冬冬,等.中藥內(nèi)服聯(lián)合針刺與埋針?lè)ㄖ委熡啄陱?qiáng)直性脊柱炎[J].中醫(yī)正骨,2016,28(01):41.
[14]赫軍,諸葛天諭,李冬冬,等.四聯(lián)療法治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2016,28(06):50.
[15]張遂連,袁星星.自我管理在強(qiáng)直性脊柱炎患者門診護(hù)理中的應(yīng)用[J].中醫(yī)正骨,2017,29(03):79.
[16]李現(xiàn)林,薛華珍,陳星,等.口服通痹舒筋丸治療強(qiáng)直性脊柱炎寒濕痹阻證[J].中醫(yī)正骨,2017,29(05):31.
[17]龔家川.影響強(qiáng)直性脊柱炎患者髖關(guān)節(jié)受累的危險(xiǎn)因素分析[J].中醫(yī)正骨,2017,29(06):25.
GONG Jiachuan.Analysis of risk factors for affection of hip joint in patients with ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(08):25.
[18]黃小龍,全仁夫,胡華輝,等.HLA-B2704基因型強(qiáng)直性脊柱炎患者來(lái)源的人誘導(dǎo)多能干細(xì)胞體系的建立[J].中醫(yī)正骨,2017,29(12):11.
HUANG Xiaolong,QUAN Renfu,HU Huahui,et al.Establishment of human-induced pluripotent stem cells system originated from patients with HLA-B2704 genotypic ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(08):11.
[19]李洛宜,張依山,王笑青,等.系列化視頻在強(qiáng)直性脊柱炎健康教育中的應(yīng)用[J].中醫(yī)正骨,2018,30(03):78.
[20]任偉凡,胡勁濤,全仁夫,等.強(qiáng)直性脊柱炎易感基因的相關(guān)研究進(jìn)展[J].中醫(yī)正骨,2019,31(04):48.